- Home
- ATRC vs BLFS Comparison
ATRC vs BLFS Comparison
Compare ATRC & BLFS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ATRC
- BLFS
- Stock Information
- Founded
- ATRC 2000
- BLFS 1987
- Country
- ATRC United States
- BLFS United States
- Employees
- ATRC N/A
- BLFS N/A
- Industry
- ATRC Medical/Dental Instruments
- BLFS Medical/Dental Instruments
- Sector
- ATRC Health Care
- BLFS Health Care
- Exchange
- ATRC Nasdaq
- BLFS Nasdaq
- Market Cap
- ATRC 1.6B
- BLFS 1.3B
- IPO Year
- ATRC 2005
- BLFS 1989
- Fundamental
- Price
- ATRC $33.13
- BLFS $24.14
- Analyst Decision
- ATRC Strong Buy
- BLFS Strong Buy
- Analyst Count
- ATRC 9
- BLFS 5
- Target Price
- ATRC $52.00
- BLFS $30.60
- AVG Volume (30 Days)
- ATRC 618.7K
- BLFS 341.7K
- Earning Date
- ATRC 10-29-2025
- BLFS 11-06-2025
- Dividend Yield
- ATRC N/A
- BLFS N/A
- EPS Growth
- ATRC N/A
- BLFS N/A
- EPS
- ATRC N/A
- BLFS N/A
- Revenue
- ATRC $518,304,999.00
- BLFS $100,144,000.00
- Revenue This Year
- ATRC $16.90
- BLFS $25.65
- Revenue Next Year
- ATRC $12.29
- BLFS $14.81
- P/E Ratio
- ATRC N/A
- BLFS N/A
- Revenue Growth
- ATRC 15.80
- BLFS 87.53
- 52 Week Low
- ATRC $28.29
- BLFS $19.10
- 52 Week High
- ATRC $43.11
- BLFS $29.62
- Technical
- Relative Strength Index (RSI)
- ATRC 45.22
- BLFS 32.85
- Support Level
- ATRC $31.12
- BLFS $25.49
- Resistance Level
- ATRC $33.98
- BLFS $28.21
- Average True Range (ATR)
- ATRC 1.80
- BLFS 1.00
- MACD
- ATRC -0.00
- BLFS -0.44
- Stochastic Oscillator
- ATRC 39.16
- BLFS 11.00
About ATRC AtriCure Inc.
AtriCure Inc is an innovator in surgical treatments and therapies for atrial fibrillation (Afib), left atrial appendage (LAA) management, and post-operative pain management and sells its products to medical centers through its direct sales force and distributors. Its product line includes Cryo, Soft Tissue Dissection, RF Ablation Pacing and Sensing, and others. Geographically, it generates a majority of its revenue from the United States. Cardiac ablation and left atrial appendage management (LAAM) products are used by physicians during open-heart and minimally invasive surgical procedures. Pain management solutions are used by physicians to freeze nerves during cardiothoracic or thoracic surgical procedures.
About BLFS BioLife Solutions Inc.
BioLife Solutions Inc is a life sciences company that develops, manufactures, and markets bioproduction products and services that are designed to improve quality and de-risk biologic manufacturing, distribution, and transportation in the cell and gene therapy ("CGT") industry. The company provides solutions such as Cell Processing, Cold Chain, and Thawing. The company generates the majority of its revenue from Cell Processing through the biopreservation product "CryoStor". Geographically the company generates the majority of its revenue from the United States.